On June 14, Mrs. Jiao Hong, deputy director of the China Food and Drug Administration (CFDA), and other officials came to Suzhou to survey and study the medical device industry. VINNO was honored to have been selected as a representative of an independent, innovative medical equipment provider, and the officials visited the company to learn about its operations.

Survey leaders included Wang Zhexiong, director of the CFDA Department of Medical Device Registration; Zhang Zhijung, vice president of the National Institutes for Food and Drug Control; Kong Fanpu, director of the Center for Medical Device Evaluation; Li Jingli, director of the CFDA Medical Device Standards Institute; Hu Xiaoshu, Yu Shanjun, and Zhao Qi, officials of the Jiangsu Food and Drug Administration; and Suzhou and SIP officials.

During the visit, Mr. Xi Shui, CEO of VINNO, presented a detailed overview of the company's R&D, production, operation, and development. Jiao inspected VINNO's color ultrasound machines and carefully examined the production base. After assessing the VINNO software facilities, hardware facilities, and workflow, she offered valuable feedback and insight. She noted that supply chain management is key to success in the Chinese medical industry. Thanks to strict controls for each production step, VINNO ultrasound machines employ modern designs and sophisticated technology. Jiao commended VINNO's innovative technology and rigorous approach, and she praised the company's achievements in the high-end medical device industry. She urged the company to take advantage of development opportunities, commit to developing new products, focus on innovation, and continue to provide high-quality products and services.

Xi thanked Jiao and the other officials for their analysis and stated that, from the beginning, VINNO has strived to produce high-end color ultrasound equipment. For this reason, VINNO engineers extensively studied leading color ultrasound products, and today, all VINNO products meet, and sometimes even surpass, international standards. In six short years, VINNO mastered all essential ultrasound technologies and emerged as a leading producer of advanced medical devices in China.  Xi noted that the company was grateful for the support of government initiatives and officials at every level. He concluding by recognizing each VINNO employee's contribution to the company's success, and recommitted the company to its vision of creating a world-class, high-end ultrasound technology brand in China.